277 related articles for article (PubMed ID: 17996892)
21. Neuropeptide-Y stimulation of extracellular signal-regulated kinases in human erythroleukemia cells.
Keffel S; Schmidt M; Bischoff A; Michel MC
J Pharmacol Exp Ther; 1999 Dec; 291(3):1172-8. PubMed ID: 10565839
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptide Y inhibits double peaked vasoconstrictor responses to periarterial nerve stimulation primarily through prejunctional Y2 receptor subtype in canine splenic arteries.
Yang XP; Chiba S
Auton Autacoid Pharmacol; 2002 Apr; 22(2):119-26. PubMed ID: 12568129
[TBL] [Abstract][Full Text] [Related]
23. Neuropeptide Y, an orexigenic hormone, regulates phagocytic activity of lizard splenic phagocytes.
Kumar S; Rai U
Peptides; 2011 Jun; 32(6):1324-9. PubMed ID: 21527297
[TBL] [Abstract][Full Text] [Related]
24. Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs.
Revington M; Lacroix JS; Potter EK
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):823-31. PubMed ID: 9457655
[TBL] [Abstract][Full Text] [Related]
25. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
[TBL] [Abstract][Full Text] [Related]
26. NPY Y(1) receptors are involved in cardio-respiratory responses to intravenous injection of neuropeptide Y in anaesthetized rats.
Kaczyńska K; Szereda-Przestaszewska M
Pharmacol Res; 2010 Nov; 62(5):444-9. PubMed ID: 20600918
[TBL] [Abstract][Full Text] [Related]
27. Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.
Heredia MP; Fernández-Velasco M; Benito G; Delgado C
Br J Pharmacol; 2002 Apr; 135(7):1701-6. PubMed ID: 11934810
[TBL] [Abstract][Full Text] [Related]
28. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein.
Smyth L; Bobalova J; Ward SM; Keef KD; Mutafova-Yambolieva VN
Auton Neurosci; 2000 Dec; 86(1-2):18-29. PubMed ID: 11269921
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
Browning KN; Travagli RA
J Physiol; 2003 Jun; 549(Pt 3):775-85. PubMed ID: 12730340
[TBL] [Abstract][Full Text] [Related]
30. Cardiac function in neuropeptide Y Y4 receptor-knockout mice.
Smith-White MA; Herzog H; Potter EK
Regul Pept; 2002 Dec; 110(1):47-54. PubMed ID: 12468109
[TBL] [Abstract][Full Text] [Related]
31. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
32. Cardiac enkephalins attenuate vagal bradycardia: interactions with NOS-1-cGMP systems in canine sinoatrial node.
Farias M; Jackson K; Johnson M; Caffrey JL
Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2001-12. PubMed ID: 12881216
[TBL] [Abstract][Full Text] [Related]
33. Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs.
Potter EK; Tripovic D
Exp Brain Res; 2006 Aug; 173(2):346-52. PubMed ID: 16733694
[TBL] [Abstract][Full Text] [Related]
34. In vivo direct monitoring of vagal acetylcholine release to the sinoatrial node.
Shimizu S; Akiyama T; Kawada T; Shishido T; Yamazaki T; Kamiya A; Mizuno M; Sano S; Sugimachi M
Auton Neurosci; 2009 Jun; 148(1-2):44-9. PubMed ID: 19278905
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y stimulates bile secretion via Y1 receptor in the left dorsal vagal complex in rats.
Yoneda M; Nakamura K; Yokohama S; Tamori K; Sato Y; Aso K; Aoshima M; Kono T; Makino I
Hepatology; 1998 Sep; 28(3):670-6. PubMed ID: 9731557
[TBL] [Abstract][Full Text] [Related]
36. Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse.
Smith-White MA; Iismaa TP; Potter EK
Br J Pharmacol; 2003 Sep; 140(1):170-8. PubMed ID: 12967946
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Yeo A; Henderson G
Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
[TBL] [Abstract][Full Text] [Related]
38. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways.
Ohtomo Y; Ono S; Zettergren E; Sahlgren B
Acta Physiol Scand; 1996 Sep; 158(1):97-105. PubMed ID: 8876753
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
